Financhill
Back

SPDR® Portfolio Developed Wld ex-US ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Buy
58

SPDW
SPDR® Portfolio Developed Wld ex-US ETF

Last Price:
35.15
Seasonality Move:
0.06%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.45
Seasonality Move:
3.65%
Buy
58
SPDR® Portfolio Developed Wld ex-US ETF (SPDW) is a Buy

Is SPDR® Portfolio Developed Wld ex-US ETF a Buy, Sell or Hold?

  • The current SPDR® Portfolio Developed Wld ex-US ETF [SPDW] share price is $35.47. The Score for SPDW is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SPDW is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SPDW Stock Price Chart

What is SPDR® Portfolio Developed Wld ex-US ETF's stock price today?

  • The SPDR® Portfolio Developed Wld ex-US ETF share price today is $35.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SPDW is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

SPDW Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 42.84 Sell
Chaikin Money Flow: 705576 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.75 - 36.47) Sell
Bollinger Bands (100): (34.41 - 36.09) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

SPDW Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.73 Sell
20-day SMA: 36.03 Sell
50-day SMA: 35.62 Sell
200-day SMA: 33.66 Buy
8-day EMA: 35.74 Sell
20-day EMA: 35.9 Sell
50-day EMA: 35.72 Sell
200-day EMA: 34.24 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

SPDR® Portfolio Developed Wld ex-US ETF Earnings Growth & SPDW Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

SPDR® Portfolio Developed Wld ex-US ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):